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Abstract 
 
 In vivo evidence demonstrates that the initial febrigenic signal from the periphery 
is communicated to the anterior hypothalamus (AH), the thermoregulatory center of the 
brain, via ascending projections of the hepatic vagus nerve.  The subsequent release of 
Norepinephrine (NE) in the AH is a key intermediary of the febrile response, resulting in 
two distinct phases mediated by α1 and α 2 adrenoreceptors (AR).  Activation of the α1 
AR produces a PGE2- independent rise in body temperature, whereas α2 activation yields 
a biphasic response; hypothermia followed by a PGE2-dependent temperature increase 
(Feleder et al., 2007).  What remains unknown is how these ARs modify the firing rate of 
thermoregulatory neurons within the AH to drive these phases and which cyclooxygenase 
(COX) isozyme is responsible for PGE2 production.  The action of NE in the AH was 
tested in the present study with the selective COX-2 inhibitor Meloxicam (0.1-10 µM) by 
recording single-unit activity of AH neurons in a tissue slice preparation from the adult 
male rat, in response to temperature and the selective α1 AR agonist Cirazoline (1 µM) or 
the selective α2 AR agonist Clonidine (1 µM).  All neurons were classified as either 
warm-sensitive or temperature insensitive. Warm-sensitive neurons responded to 
Cirazoline with a decrease in firing rate, while temperature insensitive neurons showed a 
firing rate increase. These findings strengthen the role of the α1 AR in quickly driving 
set-point temperature into a hyperthermic range to initiate fever in a PGE2- independent 
fashion.  In contrast, warm-sensitive neurons responded to Clonidine with an increase in 
firing rate, while temperature insensitive neurons showed a firing rate decrease.  This 
indicates the α2 AR may initially be driving an opposing hypothermia, but COX-2 
inhibition eliminated late phase responses after α2 AR activation, suggesting that PGE2 
from this pathway is responsible for sustaining the fever initiated by α1 AR.   
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 4 
Introduction 
 
Fever and the Hypothalamus 
 
 A fever is the temporary elevation of set-point body temperature usually one to 
two degrees above normal, which is about 37˚ Celsius in humans.  The fever is a 
hallmark indicator of the immune system fighting an infection and presumably increases 
the host’s chances of survival by fostering a hostile environment for the invading 
pathogen.  As well, the slight increase in temperature enhances certain immune system, 
endocrine, and metabolic functions to hasten defense processes (Roberts, 1991). The 
maintenance of temperature during a fever must be very precise; prolonged, unmanaged 
adjustments can be fatal, as so many cellular processes depend on a narrow window of 
temperature in which to properly function.  Thermoregulation is thus of utmost 
significance and investigation may improve clinical understanding of mechanisms behind 
certain illnesses, hot-flashes, and immune system function.   
 Achieving this rise in temperature involves a complicated series of coordinated 
autonomic, endocrine, and behavioral events, all of which are ultimately controlled by the 
hypothalamus, the body’s central thermostat (Boulant, 1992).  The hypothalamus is 
centrally located in a region known as the diencephalon, at the base of the forebrain just 
above the brainstem.  It is bound by the optic chiasm rostrally and midbrain tegmentum 
caudally, forming the floor and ventral wall of the third ventricle.  This unique orientation 
allows the hypothalamus to function as an autonomic integrator; comparing sensory 
inputs from visceral, somatic, chemoral and humoral pathways with those from higher 
areas such as the cerebral cortex, amygdala, and hippocampus (Purves et al., 2004).  
Noting discrepancies between these varying inputs and serving as a reference, the 
 5 
hypothalamus has control over a variety of effector systems to establish homeostasis and 
elicit necessary behavioral responses.   
 The anterior hypothalamus (AH) is the region of chief importance in 
thermoregulation, as it receives input from skin and spinal thermoreceptors to monitor 
temperature throughout the body (Boulant, 2000).  Within this area are distinct 
populations of neurons that can be defined by their inherent ability to respond to changes 
in temperature.  This classification is typically done by recording action potential firing 
rate in response to induced changes in temperature.  A thermosensitivity coefficient (m, 
impulses·s-1·˚C-1) can be determined from the regression line slope of a plot comparing 
firing rate and temperature.  A wide body of in vivo research has correlated changes in 
temperature with neuronal activation and initiation of thermal responses; these criteria 
can be used to determine a neuron’s thermal properties (Boulant and Hardy, 1974).    
 The majority of AH neurons are temperature insensitive (I; m < 0.80); that is their 
firing rate remains relatively constant despite changes in temperature.  Constituting about 
70% of the neurons in the AH, the consistent input of insensitive neurons is believed to 
function as reference point by which to establish a temperature set-point (Boulant, 2006).  
Approximately 20% are warm-sensitive neurons (W; m ≥ 0.80) who robustly increase 
their firing rate in response to warming.  This distinction between warm-sensitivity and 
insensitivity is determined by differences in ionic conductance during depolarizing pre-
potentials, rather than temperatures effects on resting membrane potential (Zhao and 
Boulant, 2005).  After an action potential, there is a fast hyperpolarization followed by a 
delayed depolarization which will lead to threshold and generation of a subsequent action 
potential.  Insensitive neurons show little change in the depolarizing prepotential, thus the 
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interspike period remains consistent, generating strong pacemaker activity (Griffin et al., 
1996).   On the other hand, warm-sensitive neurons show an increase in the depolarizing 
prepotential in response to temperature increases, which is likely due to inactivation of an 
outward hyperpolarizing potassium current, referred to as IA (Griffin et al., 1996).   As a 
result, warm-sensitive neurons can reach threshold much more rapidly, shortening the 
interspike period, leading to an increased firing rate.    
 
 
 
 
Figure 1, from Griffin et al. (1996). Intracellular recordings illustrating differences 
between interspike interval for insensitive (A; m = 0), slightly warm-sensitive (B, m = 
0.5), and warm-sensitive (C, m = 1.1) neurons during induced increases in temperature.   
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Figure 2, from Griffin et al. (1996). Intracellular recordings of insensitive (A) and warm-
sensitive (B) neurons in response to increases in temperature.  Note in B the shortening of 
the depolarizing prepotential as temperature increased.   
 
 In addition to different electrical properties, insensitive and warm-sensitive 
neurons can be characterized by unique morphology in the AH.  Warm-sensitive neurons 
orient their dendrites medially to the third ventricle and laterally to the medial forebrain 
bundle (Griffin et al., 2001).  This positioning is believed to aid the integration of the 
thermal input from two higher and lower afferent pathways (Boulant, 2006).  In contrast, 
insensitive neurons are situated parallel to the midline third ventricle, away from lateral 
inputs that synapse on warm-sensitive neurons.  The lack of thermal input is consistent 
with the function of insensitive neurons; pacemakers to provide a constant reference 
signal.   
 
Hammel’s Model of Thermoregulation 
 The model proposed by Hammel (1965), which has endured as a simple, yet 
valuable explanation of hypothalamic thermoregulatory interactions, must be examined in 
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order to understand how these neurons can work to raise body temperature during a fever.  
It is centered around the action of warm-sensitive and insensitive neurons, as well, it 
details heat-loss effector neurons and heat-production effector neurons.  The insensitive 
and warm-sensitive neurons send antagonistic, synaptic inputs to these effector neurons 
which control thermoregulatory responses.  Warm-sensitive neurons can excite heat-loss 
effector neurons and inhibit heat-production effector neurons; insensitive neurons inhibit 
and excite these effector neurons, respectively.  A temperature set-point is established 
when the firing rate of insensitive neurons matches that of warm-sensitive neurons.  
Sensing an increase in temperature from afferent inputs, warm-sensitive neurons increase 
their firing rate relative to the insensitive neurons.  This deviation from set-point would 
stimulate heat-loss effector neurons, which could initiate responses such as panting, 
sweating, and vasodilatation.  During cooling, the firing rate of warm-sensitive neurons 
would decrease while firing rate of insensitive neurons would remain relatively 
unchanged.  With this comparative shift of firing rates, the insensitive neurons would 
inhibit heat-loss effector neurons and excite heat-production effector neurons, which may 
promote processes of shivering, vasoconstriction, or thermogenesis via uncoupling of 
oxidative phosphorylation pathways.  It is important to note that each thermoregulatory 
response has its own set-point, thus different responses will be initiated at different 
temperatures.   
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Figure 3, adapted from Boulant (2006).  Hammel’s model of thermoregulation.  The two   
neurons labeled W are warm-sensitive, the other two labeled I are insensitive.  They send 
antagonistic synapses with warm and cold effector neurons, indicated by diamond shaped 
W or C neurons, respectively.  A + or – indicates an excitatory or inhibitory effect.  See 
above text for details.  SP: dorsal horn spinal neuron; OC: optic chiasm; MB: mammilary 
body, FR: firing rate.   
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 The presence of pyrogens or endotoxins can also affect the activity of AH 
thermoregulatory neurons, as is the case during a fever.  The mediators of these toxins 
will inhibit the activity of warm-sensitive neurons; this relative decrease compared to the 
insensitive neurons would inhibit heat-loss responses while enhancing heat-production 
responses, and the set-point temperature would be elevated (Boulant, 2000).  With 
pyrogens present, all responses will have elevated set-point temperatures, presumably, 
once levels decrease, the firing rate of warm-sensitive neurons will return to their 
previous, higher level.  This would enhance heat-loss responses and bring body 
temperature back down to normal.   
 
Initiation of the Fever Response 
 The immune system responding to an invading pathogen, through a reaction to an 
endotoxin such as lipopolysaccharide (LPS), is responsible for communicating with the 
hypothalamus to adjust set-point temperature as described above.  The traditional view 
has been that pathogens stimulate phagocytes to synthesize and release pyrogenic 
cytokines into the blood stream.  Cytokines, as an endocrine signal, are then transported 
in the circulation and move through the blood-brain barrier (Banks et al, 1995), where 
their arrival in the AH will induce the expression of Cyclooxygenase-2 (COX-2) and 
subsequent synthesis of Prostaglandin E2 (PGE2), a well-established a fever mediator 
(Blatteis and Sehic, 1997).      
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Figure 4, from Blatteis (2005).  A schematic highlighting the events of the “classic” 
fever response.  ExP: external pyrogen; IL: interleukin; TNF: tumor necrosis factor; 
POA: preoptic-anterior hypothalamus; Tc↑: core temperature rise.   
 
 
 
 However, this traditional mechanism of the cytokine-induced febrile response has 
been re-evaluated because of time course discrepancies in the sequence of events.  What 
has been overlooked is that the production of these signals, which affect transcription 
rates and gene expression, is a slow process, happening on the order of hours.  The 
appearance of circulating cytokines lags the onset of the febrile response when LPS is 
intravenously injected, as well; the expression of COX-2 only appears well after the onset 
of fever (Blatteis, 2005).  Additionally, cytokine levels remain very high once the fever 
has abated and the transport of cytokines across the blood-brain barrier remains very 
controversial.  Evidence now clearly establishes that the initial febrigenic message from 
the immune system is conveyed to the hypothalamus via a much faster means; a neural 
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route.  The hepatic division of the parasympathetic vagus nerve initially was implicated 
in this regard, as its surgical removal or destruction prevented the prompt generation of a 
fever in response to LPS (Simons et al, 1998; MohanKumar et al, 2000).  Further 
research has supported these findings, with the liver and vagus emerging as central 
intermediaries in the recently elucidated endotoxic febrile response.    
 Upon arrival in the liver, injected LPS is taken up by Kupffer cells (Kc) and a 
complement cascade is activated.  Kc are unique because they express constitutive levels 
of both COX-1 and COX-2 enzymes and have PGE2 available for quick, almost 
instantaneous release (Blatteis, 2000).  The complement promotes Kc to release PGE2, 
which stimulates hepatic vagal afferents possessing Prostaglandin E receptors (EP) that 
project to the AH (Li et al., 2006; Wieczorek and Dunn, 2006).  Noradrenergic afferents 
of the vagus travel from the brainstem through the ventral noradrenergic bundle and 
synapse in the AH, where there are numerous noradrenergic terminals (Kumar et al, 
2007).  It is the release of Norepinephrine (NE) via these autonomic routes which 
mediates the febrile response to peripheral LPS in the AH (Feleder et al., 2007).  NE acts 
at adrenoreceptors (AR) in the AH to initiate two distinct thermal responses; a rapid, 
initial hyperthermia independent of PGE2 and a later one that is dependent on COX-2 
induction and PGE2 synthesis (Feleder et al, 2004).  The ARs and prostaglandins will be 
analyzed separately in depth to better understand their intricate relationship in the 
hypothalamus during fever.   
 
Norepinephrine as a Fever Mediator: the Role of Adrenoreceptors 
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 Adrenoreceptors are G-protein coupled receptors (GPCR) widely distributed in 
the CNS; they are the targets of NE and epinephrine and are typically involved in 
autonomic responses.   There are two families of AR, α and β, which can further be 
broken down into various subtypes.  Binding of NE at α1 ARs stimulates Phospholipase 
C (PLC) activity, which catalyzes the hydrolysis of phosphatidylinositol (PIP2), resulting 
in formation of inositol triphosphate (IP3) and diacylglycerol (DAG).   IP3 is an important 
regulator of intracellular calcium levels by binding to selective channels of the 
endoplasmic reticulum.  DAG remains in the inner membrane leaflet and can go on to 
stimulate a variety of other pathways.  Typically in the CNS, activation of α1 ARs will 
result in depolarization and an increase in firing rate, as well as increasing sodium-
potassium pump activity to restore concentration gradients (Mallick et al, 2000).  In 
contrast to α1 ARs, α2 ARs are GPCR which act to reduce PLC activity.  As well as 
indirectly lowering Ca2+ levels, the α2 AR can also inhibit adenylate cyclase, 
subsequently reducing cyclic AMP (cAMP) production.   
 These two AR subtypes have different second messenger pathways, which may 
indirectly explain differences in the thermal responses mediated by each receptor.  In fact 
many neurons possess mixtures of both α1 and α2 ARs in their synaptic membranes, thus 
adding another level of complexity and more elaborate control of neurotransmission 
(Siegel et al., 1999).  The application of NE in the AH will increase the frequency of 
spontaneous, miniature inhibitory postsynaptic currents (mIPSCs) via the α1 AR and 
likewise decrease the frequency of IPSCs via the alpha-2 AR (Kolaj and Renaud, 2007).  
This observation indicates that these two ARs can modify rapid, GABA-mediated 
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inhibitory transmission and thus have a central role in regulating excitability within this 
noradrenergic network of thermoregulatory neurons.   
 Application of Cirazoline in vivo, a NE agonist that acts selectively at the α1 AR, 
produced a quick rise in core body temperature independent of PGE2 that attenuated 
within hours.  It appears activation of the α1 AR is important in the genesis of fever; it 
has been demonstrated that Cirazoline directly augments the firing rates of 
thermosensitive neurons within the AH in vitro, a decrease and increase in warm-
sensitive and insensitive neurons respectively (Imbery et al., 2008).  These contrasting 
responses would activate heat-production effector neurons according to the Hammel’s 
thermoregulatory model.  
 The application of the selective α2 AR agonist Clonidine in vivo produced a 
biphasic response that directly correlated with levels of PGE2; an initial temperature fall 
followed by a later temperature rise corresponding to increased PGE2 levels (Feleder et 
al, 2004).  PGE2 has been shown to increase and decrease the firing rates of insensitive 
neurons and warm-sensitive neurons respectively, which would correspond to heat 
production according to Hammel’s model (Ranels and Griffin, 2003).  It had initially 
been accepted that the α2 AR mediates only a hypothermic response (Quan et al, 1992), 
but the latter temperature rise observed may be a result of a longer experimental 
recording duration.  Treatment with a selective COX-1 inhibitor had minimal affect, but a 
selective COX-2 inhibitor attenuated the later temperature increase.  This suggests the 
inducible COX-2 isozyme is predominantly responsible for the synthesis of PGE2 and the 
late phase response of thermoregulatory neurons in the AH.   
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PGE2 and the Prostaglandin E (EP) Receptors 
 The synthesis of PGE2 is a multi-step, tightly regulated process that is the target 
of much investigation.  Membrane bound Phospholipase A2 (PLA2) cleaves 
phospholipids into arachadonic acid (AA).  AA is converted by the COX isozymes and 
Peroxidase into the key intermediate PGH2, which is transformed to PGE2 by membrane-
bound PGE synthase (mPGES-1).  PGE2 is subsequently released from the cell, where it 
acts though four subtypes of the EP receptor, identified as 1, 2, 3, and 4, based on their 
modes of signal transduction.  The EP receptors have a seven-transmembrane domain 
that is linked to G-proteins which are involved in second messenger pathways (Siegel et 
al, 1999).  Functionally, EP1 increases intracellular Ca2+ levels, EP2 and EP4 increase 
cAMP, and EP3 is inhibitory and lowers cAMP (Lazarus, 2006).  The many targets of 
these pathways can lead to modification of ion channels, membrane receptors, and 
neurotransmitter release.   
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Figure 5, from Lazarus (2006).  Cascade of PGE2 production and key enzymes. 
 
 There remains some controversy about the signaling properties of PGE2, mainly 
whether it predominantly functions as a local signal (paracrine) or is capable of 
widespread circulatory transport (endocrine).  As a small, lipophillic molecule, it has 
been postulated to cross the blood brain barrier.  In regards to the contemporary model of 
febrigenesis, most PGE2 released by the Kc of the liver is presumed to directly stimulate 
the hepatic vagus.  But some could enter the blood stream and enter the AH, through 
“leaky” areas of the blood-brain barrier, intensifying the fever initiated by the vagal 
afferents and its stimulation of NE release.  Nonetheless, the observation that PGE2 levels 
and the temperature rise in the AH induced by peripheral pyrogen exposure are inhibited 
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by intra-AH administration of COX inhibitors suggests that PGE2 is predominantly 
generated locally in the hypothalamus, functioning as a paracrine signal (Blatteis et al., 
2005).   
 Research on the EP receptors involved in the febrile response has been 
inconclusive.  It was demonstrated that only mice lacking the EP3 receptor via 
homologous recombination showed no febrile response when exposed to LPS (Ushikubi 
et al., 1998).  Another knock-out study added more doubt when it was shown that both 
the EP1 and EP3 receptors were involved in an inflammatory febrile response (Oka et al., 
2003).  The discrepancies between these studies are likely due to differences in 
expression among various types of nervous tissue, but now more is known about the 
specific areas of the hypothalamus that these receptors are required for fever responses 
(Lazarus et al., 2007). 
 Through site-specific deletion of EP3 receptors in certain nuclei of the rat 
hypothalamus, it has been revealed that expression of EP3 receptors in the AH is crucial 
for the fever response (Lazarus et al., 2007).  Agonists of the inhibitory EP3 receptor have 
been shown to produce fever (Oka et al., 2003), presumably by an inhibition of warm-
sensitive neurons due to decreased cAMP levels.  In contrast, EP4 receptors, are 
implicated in hypothermic responses (Lazarus et al, 2006).  The differences in EP 
subtype expression and their contrasting thermal responses add another degree of 
complexity to febrigenesis.  Due to their properties, it may be probable that EP3 receptors 
are predominantly found on warm-sensitive neurons; likewise EP4 receptors would be 
localized to insensitive neurons.    
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 The regulation of COX-2 must be addressed to understand PGE2 synthesis and its 
contribution to the distinct phases of fever.  Of the COX enzymes, COX-1 is the 
constitutive form and COX-2 is the inducible type in most tissues, but constitutive levels 
are present in some neurons, dendrites, and astrocytes; its expression can be regulated 
quickly by inflammatory stimuli (Siegel et al., 1999).  COX-2 appears to be the isozyme 
of central importance; in addition to almost completely abolishing fever, the 
administration of a COX-2 inhibitor after exposure to LPS will prevent the expression of 
Fos (a proto-oncogene that is up-regulated in response to activating stimuli) in anterior 
areas of the hypothalamus (Zhang et al., 2003).  Less is known about the role of COX-1 
and its involvement in fever production.  It appears that COX-1 derived prostaglandins 
have unique roles in certain areas, especially the brainstem, perhaps as alternate routes to 
communicate with the CNS about inflammatory stimuli (Zhang et al., 2003).  The 
expression of COX-1 and baseline PGE2 production in these pathways along with COX-2 
expression in the hypothalamus may be necessary to fully activate the autonomic nervous 
system during a febrile response.  
 
Current Model of Fever in Response to an Immune Challenge 
 The current model suggests there is a dynamic interplay between NE and PGE2 
within the AH.  The vagal-stimulated release of NE in the AH acts at two 
adrenorecpetors.   The α1 AR is responsible for early phase febrigenesis, and directly 
augments the firing rates of warm-sensitive and insensitive neurons according to 
Hammel’s model to bring about this temperature rise.  NE acting at the α2 AR stimulates 
an initial hypothermia and via second messenger pathways induces COX-2 expression 
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and PGE2 formation.  The subsequent PGE2 release acts at EP receptors, activating 
second messenger pathways bringing about late phase fever response via the inhibition of 
warm-sensitive neurons or activation of temperature insensitive neurons in accord with 
Hammel’s model.
 
 
 
Figure 6, from Feleder et al. (2004).  Schematic of NE and PGE2 interaction in the 
Hypothalamus.  See above text for details 
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Figure 7, from Blatteis (2005).  Diagram summarizing the proposed pathway of the 
biphasic febrile response mediated by NE and PGE2.  See text for details.   
 
Project Summary and Objectives 
 This project was undertaken to provide more insight into the interaction of NE 
and PGE2 within the AH during the fever.  Specifically, I aim to confirm in vivo work 
demonstrating COX-2 independence of the α1 AR response and a COX-2 dependence of 
the late-phase α2 AR response using in vitro tissue slice preparations.  Single-unit 
experiments are invaluable to the further neuronal understanding of thermoregulation 
during early and late-phase responses in the AH.   
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Hypotheses: 
 Treatment with the selective COX-2 inhibitor Meloxicam will have no affect on 
the responses of thermoregulatory neurons (a decrease and increase in warm-sensitive 
and insensitive neurons respectively) when treated with Cirazoline, the α1 AR agonist.  
Treatment with the same COX-2 inhibitor will abolish the late-phase thermal responses 
of these thermoregulatory neurons when treated with Clonidine, the α2 AR agonist, as it 
is likely a PGE2 dependent process.   
 
Methodology 
 To record the single-unit activity of AH neurons, brain tissue slices containing the 
AH were prepared from male Sprague-Dawley rats (Harlan; 100-150 grams), which were 
housed under standard conditions and provided unlimited food and water.  Before each 
recording session, a rat was anesthetized using isoflurane and promptly decapitated, 
following procedures that have been approved by the Animal Care and Use Committee of 
the College of William and Mary.  After dissection of the brain, a tissue block containing 
the hypothalamus was mounted on a vibratome and bathed in artificial cerebral spinal 
fluid (aCSF).  One to three 400 or 500 µm thick tissue slices (saggital or coronal plane) 
were cut and then placed in an interface style recording chamber and allowed to 
equilibrate for an hour before recordings were made.  Tissue slices were perfused with 
aCSF, which consisted of (in mM): 124 NaCl, 26 NaHCO3, 10 glucose, 5 KCl, 2.4 CaCl2, 
1.3 MgSO4, and 1.24 KH2PO4 (Sigma Chemicals).  The water-soluble, selective COX-2 
inhibitor Meloxicam (Sigma Chemicals) was also dissolved in the aCSF solution at 
concentrations of 0.1 – 10 µM on the day of the recording.  The perfusion medium was 
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gently aerated (95% O2 – 5% CO2) and allowed to gravity flow at 1-2 ml.minute-1 into the 
recording chamber (volume = 2 ml).  Temperature was maintained ~36°C except for 
periodic warming and cooling to characterize the thermosensitivity of recorded neurons. 
A thermocouple was placed below the tissue slices to constantly monitor temperature.  
 To confirm the PGE2 independence or dependence of the α1 and α2 AR response, 
Cirazoline or Clonidine (Sigma Chemicals) was diluted to 1 µM in the same aCSF + 
Meloxicam solution and oxygenated in a separate perfusion tube, which could be 
switched to the primary perfusion line in place of the aCSF + Meloxicam only medium 
by means of a valve control system.  Thus at all times the tissue was exposed to aCSF + 
Meloxicam, and Clonidine or Cirazoline only introduced in the recording chamber during 
treatment periods.   
 To characterize the firing rate activity of individual neurons in the AH, single-unit 
recordings were made of electrical activity.  Recordings were made using glass 
microelectrodes pulled to a tip diameter of ~1 µm and filled with a 3 M NaCl solution. 
Electrical activity was amplified and filtered using a Xcell-3 microelectrode amplifier 
and acquisition processor module system (FHC Inc.).  An acceptable single-unit 
recording required potential amplitudes with a signal-to-noise ratio greater than 3:1. 
Firing rate was determined through the use of a Rate/Interval Monitor (FHC Inc.) and 
was continuously recorded, along with temperature, on a computer using Axoscope 
software (Molecular Devices).  Once the activity of a single neuron had been isolated and 
firing rate recorded for an initial period of stability, temperature was varied 1-3 oC above 
and below the baseline temperature (~36 °C) by changing the input voltage to a 
thermoelectric heating assembly through which the perfusion media flowed before 
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entering the chamber.  Neuronal thermosensitivity (impulses·s-1·°C-1) was later 
characterized by plotting firing rate as a function of temperature to determine the 
regression coefficient (m) of this plot. As in previous studies (Kelso et al., 1982; Fetsch et 
al., 2006), warm sensitivity was characterized by a regression coefficient of at least 0.8 
impulses·s-1·°C-1. All other neurons in this study were classified as temperature 
insensitive. 
 Tissue temperature was again stabilized at a baseline level and the perfusion 
medium was switched from normal aCSF + Meloxicam to one containing Cirazoline or 
Clonidine.  Perfusion with Cirazoline or Clonidine continued for 10 minutes or until a 
change in firing rate of at least 15% occurred.  Cirazoline or Clonidine was then removed 
from the recording chamber by perfusion with normal aCSF + Meloxicam for at least 10 
minutes. Occasionally, after a neuron’s firing rate activity recovered to a stable level, a 
second perfusion with Cirazoline or Clonidine was performed.   
 To determine if there was a significant change in a neuron’s firing rate in response 
to Cirazoline, firing rate measurements were collected for three segments (at 60 Hz): one 
minute before the beginning of perfusion with experimental solutions (Baseline), one 
minute during the peak of the response or immediately preceding the end of the 
experimental perfusion (Treatment), and one minute at the end of the following perfusion 
with previous solutions (Washout).  For each segment, a mean and standard error were 
determined.  A change in firing rate was considered significant between Baseline and 
Treatment if it was at least 15% and there was a significant difference at p < 0.05 
(Student’s t-test).   
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 Neurons treated with Clonidine were analyzed similarly, but with another 
criterion in order to measure any late phase responses due to PGE2.  After the initial 
treatment of Clonidine, if possible, a period of at least thirty minutes was allowed to pass, 
since most evidence suggests the synthesis of PGE2 requires approximately twenty to 
thirty minutes in response to an inflammatory signal (Simmons et al., 2004).  Neurons 
that were able to be recorded for a prolonged period of time (such as one and a half to 
two hours) and recovered to a stable firing rate after initial Clonidine treatment were 
considered for late phase analysis.  The washout firing rate served as a new baseline, and 
in a similar manner, cells were analyzed for any changes in firing rate during this late 
period.  Responses from a previous study on the affects of PGE2 in the AH (Ranels and 
Griffin, 2003) served as a guideline to examine any late phase responses.   
 After each recording, the location and depth of the electrode was noted on a 
section diagram adapted from an atlas of the rat brain (Paxinos and Watson, 1998).  At 
the end of the recording session, tissue slices were removed from the chamber, fixed in a 
formalin solution, and placed in a 30% sucrose solution before being sectioned to a 
thickness of 40 - 50 µm.  Sections were then mounted on gelatin coated slides and stained 
with giemsa to identify specific hypothalamic areas so the location of each recording 
within the AH could be reconfirmed. 
 
Results 
 
Cirazoline and COX-2 Inhibition 
 
 The firing rates of fifteen AH neurons were recorded during changes in 
temperature and perfusion with the α1 AR agonist Cirazoline (1µM) while exposed to the 
 25 
COX-2 inhibitor Meloxicam (10 µM).  With a criterion for warm sensitivity of m ≥ 0.8 
impulses·s-1·°C-1, two neurons were classified as warm-sensitive while the majority (n = 
13) were classified as temperature insensitive.  Figure 8 shows the percent change in 
firing rate responses to Cirazoline for each neuron, plotted as a function of the neuron's 
thermosensitivity.  Nine of the temperature insensitive neurons showed significant 
increases in firing rate, greater that a 15% change during perfusion with Cirazoline.  
There were two insensitive neurons who did not respond significantly, with percent 
changes less than 15%.  Two other insensitive neurons showed very dramatic increases, 
lying well outside the range of the rest of the data with over 650% changes.  The two 
warm-sensitive neurons decreased their firing rate by about 40 and 100% (which reflects 
a complete shutdown of firing). 
 
 26 
 
Figure 8.  The firing rate responses of AH neurons to Cirazoline under COX-2 inhibition. 
The percent change in firing rate for all neurons (N = 15) in response to Cirazoline is 
plotted against thermosensitivity. A neuron was classified as warm-sensitive if it had a 
thermosensitivity ≥ 0.8 impulses·s− 1.°C− 1, represented by squares ■ in the figure. All 
other neurons were classified as insensitive, represented as circles ● 
 
 Overall, the difference between baseline and treatment periods for the insensitive 
neurons was not significant at the p < 0.05 level, but was at p < 0.10 (Paired t–test p = 
0.08).  The two warm-sensitive neurons responded to Cirazoline with decreases in firing 
rate, but overall these differences were not significant (Paired t–test p = 0.26) compared 
to baseline.  Table 1 summarizes the changes in firing rates of these neurons during the 
three measurement conditions of baseline, treatment, and washout.  As a population, the 
temperature insensitive neurons significantly increased their firing rates from a mean of 
4.02 impulses·s− 1 during baseline conditions, to 10.07 impulses·s− 1 during perfusion with 
Cirazoline.  In contrast, the mean firing rate of the warm-sensitive neurons decreased 
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from 2.84 impulses·s− 1 to 1.46 impulses·s− 1.  Seven temperature insensitive neurons did 
recover to a stable firing rate after Cirazoline treatment, the mean washout FR of these 
neurons was slightly lower than baseline at 2.08 impulses·s− 1.  Among the warm-
sensitive neurons, only one showed a stable recovery after Cirazoline treatment, it 
returned to a FR of 1.92 impulses·s− 1.  The other warm-sensitive neuron remained 
inhibited for the duration of the recording after treatment.  Because of the lack of warm-
sensitive cells recorded, the standard error (SE) within this data group is very high.   
 
 
Cirazoline with COX-2 inhibition (Meloxicam) 
 
     Firing Rate-FR (impulses/sec ± SE) 
 
Cell Type N  Baseline  Treatment           Washout__ 
Insensitive      13          4.02 ± 0.66           10.07 ± 3.51*         2.08 ± 0.92 
 
Warm  2          2.84 ± 2.06            1.46 ± 1.46         1.92 ± 1.92 
(* denotes significant difference from Baseline Firing Rate.  Paired t–test p < 0.10) 
 
Table 1. Effects of Cirazoline with COX-2 inhibition on the firing rates of thermally 
classified AH neurons.   
 
 
 
 
 
 The firing rate activity of a temperature insensitive neuron with COX-2 inhibition 
during a change in temperature and perfusion with Cirazoline is shown in Figure 9. With 
respect to a variation in temperature (~ 4 °C), there was some correlation between firing 
rate, but it was not large enough to classify this neuron as warm-sensitive (m = .39). In 
response to perfusion with Cirazoline, firing rate increased from a baseline mean of 3.17 
impulses·s− 1 to 7.22 impulses·s− 1, peaking at a firing rate of 10.61 impulses·s− 1 during 
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the middle of the treatment period.  Within ten minutes from the time perfusion with 
Cirazoline was stopped, firing rate was much lower compared to baseline, 0.29 
impulses·s− 1, and then died shortly thereafter.  
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Figure 9.  The effects of temperature and Cirazoline with COX-2 inhibition on the firing rate 
activity of an AH temperature insensitive neuron. A shows the firing rate of this neuron during 
changes in temperature and Cirazoline (1 µM; indicated by the solid bar above the graph). In B, 
firing rate (60 Hz) is plotted as a function of temperature. A linear regression is indicated by the 
solid line. In C, one minute segments of firing rate activity are plotted as individual bar graphs, 
just before perfusion with Cirazoline (Baseline; 3.17 ± 0.09), during the peak of the response 
(Cirazoline; 7.22 ± 0.15), and several minutes after Cirazoline perfusion had stopped (Washout; 
0.28 ± 0.09).  
 30 
 
 The firing rate activity of a warm-sensitive neuron with COX-2 inhibition during 
a change in temperature and perfusion with Cirazoline is shown in Figure 10. With 
respect to a variation in temperature (~ 4 °C), there was a strong correlation between 
firing rate that was large enough to classify this neuron as warm-sensitive (m = 1.15). In 
response to perfusion with Cirazoline, firing rate decreased from a baseline mean of 4.50 
impulses·s− 1 to 2.52 impulses·s− 1.  Within ten minutes from the time perfusion with 
Cirazoline was stopped, firing rate had returned to a stable level, with a mean firing rate 
of 3.43 impulses·s− 1.  This washout firing rate remained stable for about twenty minutes 
before the recording was ended.   
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Figure 10.  The effects of temperature and Cirazoline with COX-2 inhibition on the firing rate 
activity of a an AH temperature insensitive neuron. A shows the firing rate of this neuron during 
changes in temperature and Cirazoline (1 µM; indicated by the solid bar above the graph). In B, 
firing rate (60 Hz) is plotted as a function of temperature. A linear regression is indicated by the 
solid line. In C, one minute segments of firing rate activity are plotted as individual bar graphs, 
just before perfusion with Cirazoline (Baseline; 4.50 ± 0.06), during the peak of the response 
(Cirazoline; 2.52 ± 0.07), and several minutes after Cirazoline perfusion had stopped (Washout; 
3.43 ± 0.05). 
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 It is important to compare this data with results from a similar study analyzing the 
effects of Cirazoline without COX-2 inhibition on AH neurons (Imbery et al., 2008).  
Again, the criterion for warm sensitivity was m ≥ 0.8 impulses·s-1·°C-1, all other neurons 
were classified as temperature insensitive.  Table 2 summarizes these changes in FR 
during each of the three measurement periods.  The population of temperature insensitive 
neurons significantly increased their firing rates from a mean of 3.4 impulses·s− 1 during 
baseline conditions, to 10.5 impulses·s− 1 during perfusion with Cirazoline.  In contrast, 
the mean firing rate of the warm-sensitive neurons significantly decreased from 3.7 
impulses·s− 1 to 0.4 impulses·s− 1.  Comparisons between the responses of Cirazoline with 
COX-2 inhibition and Cirazoline only will be addressed in the discussion for further 
analysis.   
 
Cirazoline without COX-2 inhibition  
 
    Firing Rate-FR (impulses/sec ± SE) 
 
Cell Type    N  Baseline  Treatment           Washout___   
Insensitive    37          3.41 ± 0.38           10.49 ± 1.40          2.68 ± 0.84 
 
Warm     12          3.71 ± 0.50   0.44 ± 0.19          0.41 ± 0.00 
(* denotes significant difference from Baseline Firing Rate.  Paired t–test p < 0.05) 
 
Table 2.  Effects of Cirazoline only on the firing rates of thermally classified AH 
neurons.   
 
 
 
Figure 11 provides a detailed anatomical view of the location of each recording 
made with Cirazoline and COX-2 inhibition in this study. The majority of recordings 
were from neurons in the medial preoptic and anterior hypothalamic areas, with a few 
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recordings from neurons in more lateral and dorsal areas of the areas of the 
hypothalamus.  Six temperature insensitive neurons were located in close proximity to 
the midline, and the remaining seven where in more lateral areas left and right.  The two 
warm-sensitive neurons were also located in lateral areas of the anterior hypothalamus.   
 
 
 
Figure 11.  The electrode locations for recordings of single neuron activity in response to 
temperature and Cirazoline with COX-2 inhibition. Section diagrams are shown in the 
coronal plane and ordered from rostral to caudal, beginning with the upper left section 
and moving across each row. Distance from bregma: A = − 0.5 mm; B = − 0.7 mm; 
C = − 1.0 mm; D = − 1.3 mm.  Sections were adapted from an atlas of the rat brain 
(Paxinos and Watson, 1998). Circles ● = insensitive neurons, Squares ■ = warm-sensitive 
neurons.  Key abbreviations for reference: 3V, third ventricle; ac, anterior commissure; 
AHA, anterior hypothalamic area; f, fornix; LH, lateral hypothalamus; LPO, lateral 
preoptic area; MnPO, median preoptic nucleus; MPO, medial preoptic nucleus; MPA, 
medial preoptic area; mfb, median forebrain bundle; ox, optic chiasm; Pe, periventricular 
nucleus; Sch, suprachiasmatic nucleus; StHy, striohypothalamic nuc.; VLPO, 
ventrolateral preoptic area; VMPO, ventromedial preoptic area. 
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Clonidine and COX-2 Inhibition 
 
 The firing rates of thirty AH neurons were recorded during changes in 
temperature and perfusion with the α2 AR agonist Clonidine (1µM) while exposed to the 
COX-2 inhibitor Meloxicam (0.1-10 µM).  With a criterion for warm sensitivity of m ≥ 
0.8 impulses·s-1·°C-1, three neurons were classified as warm-sensitive while the majority 
(n = 27) were classified as temperature insensitive.  Figure 12 shows the percent change 
in firing rate responses to Clonidine for each neuron, plotted as a function of the neuron's 
thermosensitivity.  Three of the temperature insensitive neurons showed an increase in 
firing rate during perfusion with Clonidine, in contrast to the majority who showed a 
significant decrease in firing rate.  Two warm-sensitive neurons responded to Clonidine 
with a significant increase in firing rate, approximately a 100% change.  One warm-
sensitive cell, whose had thermosensitivity m = 3.96, was omitted from the graph as an 
outlier because it showed an almost complete shutdown in firing rate, thus completely 
inverting the regression line.    
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Figure 12.  The firing rate responses of AH neurons to Clonidine under COX-2 
inhibition. The percent change in firing rate for all neurons (N = 30) in response to 
Clonidine is plotted against thermosensitivity. A neuron was classified as warm-sensitive 
if it had a thermosensitivity m ≥ 0.8 impulses·s− 1.°C− 1, represented by squares ■ in the 
figure. All other neurons were classified as insensitive, represented as circles ● 
 
 Table 3 summarizes the changes in firing rates of these neurons during the three 
measurement conditions of baseline, treatment, and washout.  As a population, the 
temperature insensitive neurons significantly decreased their firing rates from a mean of 
2.80 impulses·s− 1 during baseline to 1.90 impulses·s− 1 during perfusion with Clonidine.  
In contrast, the mean firing rate of the warm-sensitive neurons increased from 4.51 
impulses·s− 1 to 6.83 impulses·s− 1, but this increase was not statistically significant 
(Paired t–test p = 0.38).  Twenty temperature insensitive neurons did recover to a stable 
firing rate after Clonidine treatment, the mean washout FR of these neurons was slightly 
lower than baseline at 1.92 impulses·s− 1.  Among the warm-sensitive neurons, only one 
 36 
showed a stable recovery after Clonidine treatment, it returned to a FR of 1.15 
impulses·s− 1.  The other warm-sensitive neurons did not return to a stable FR after 
treatment.  Because of the lack of warm-sensitive cells recorded, the SE within this data 
group again is very high and there is not enough statistical power to discern any 
significant differences.  
 
Clonidine with COX-2 inhibition (Meloxicam) 
 
           Firing Rate (impulses/sec ± SE) 
 
Cell Type   N  Baseline  Treatment           Washout___   
Insensitive   27          2.80 +/- 0.35           1.90 +/- 0.46*         1.92 +/- 0.54 
 
Warm               3          4.51 +/- 1.90           6.83 +/- 5.03         0.38 +/- 0.38 
(* denotes significant difference from Baseline Firing Rate.  Paired t–test p < 0.05) 
 
Table 3.  Effects of Clonidine with COX-2 inhibition on the firing rates of thermally 
classified AH neurons.   
  
 
 
 There were nine neurons, all of which were temperature insensitive, recorded for 
a period of at least thirty minutes after the initial Clonidine treatment that were analyzed 
for a late phase PGE2 response.  None of these neurons showed any significant increase 
in firing rate compared to the washout firing rate.  Refer to Figure 13, highlighting this 
period of stability after Clonidine treatment.    
 The firing rate activity of a temperature insensitive neuron with COX-2 inhibition 
during a change in temperature and perfusion with Clonidine (1 µM) is shown in Figure 
13. With respect to a variation in temperature (~ 4 °C), there was little correlation with 
firing rate (m = .03), so it was classified as temperature insensitive.  In response to 
perfusion with Clonidine, firing rate decreased from a baseline mean of 2.22 impulses·s− 1 
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to 1.97 impulses·s− 1.  This decrease in firing rate was not statistically significant (paired 
t–test p = 0.13).  Once Clonidine perfusion was stopped, the firing rate returned to a mean 
of 1.40 impulses·s− 1 and was very stable.  The recording continued on for approximately 
100 minutes after the end of treatment, and no significant late phase increase in firing rate 
was observed.   
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Figure 13.  The effects of temperature and Clonidine with COX-2 inhibition on the firing rate 
activity of an AH temperature insensitive neuron. A shows the firing rate of this neuron during 
changes in temperature and Clonidine (1 µM; indicated by the solid bar above the graph). In B, 
firing rate (60 Hz) is plotted as a function of temperature. A linear regression is indicated by the 
solid line. In C, one minute segments of firing rate activity are plotted as individual bar graphs, 
just before perfusion with Clonidine (Baseline; 2.22 ± 0.14), during the peak of the response 
(Clonidine; 1.97 ± 0.7), and several minutes after Clonidine perfusion had stopped (Washout; 
1.40 ± 0.1). 
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 For comparison with Figure 13, the firing rate activity of an insensitive neuron 
treated with Clonidine (1 µM) but no COX-2 inhibition is shown in Figure 14.  With 
respect to a variation in temperature (~ 4 °C), there was a slight correlation with firing 
rate (m = -0.36), showing some cold sensitivity, but it is still classified as a temperature 
insensitive neuron.  A five minute perfusion with Clonidine produced a significant 
decrease in firing rate from a baseline of 4.98 impulses·s− 1 to 1.50 impulses·s− 1 (paired 
t–test p = 0.00).  After ten minutes, the cell returned to a mean washout firing rate of 6.57 
impulses·s− 1.  At approximately thirty minutes into the recording, twenty minutes since 
the Clonidine treatment, the firing rate began to drastically increase, reaching a peak 
firing rate of 45 impulses·s− 1.  This plateau response lasted about eight minutes before 
the recording was stopped, typical of an insensitive neuron responding to PGE2.   
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Figure 14.  The effects of temperature and Clonidine without COX-2 inhibition on the firing rate 
activity of an AH insensitive neuron. A shows the firing rate of this neuron during changes in 
temperature and Clonidine (1µM; indicated by the solid bar above the graph). In B, firing rate is 
plotted as a function of temperature. A linear regression is indicated by the solid line. In C, one 
minute segments of firing rate activity are plotted as individual bar graphs, just before perfusion 
with Clonidine (Baseline; 4.98 ± 0.37), during the peak of the response (Clonidine; 1.50 ± 0.09), 
and several minutes after Clonidine perfusion had stopped (Washout; 6.58 ± 0.26). Note after 
thirty minutes, there is a sustained increase in firing rate, reaching a peak of 45 impulses·s− 1 
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Figure 15 displays a detailed anatomical view of the location of each recording 
presented in this study.  While a majority of recordings were made from neurons in the 
medial preoptic and anterior hypothalamic areas, a few recordings extended well into 
posterior regions of the hypothalamus. There was no specific area of the hypothalamus in 
which temperature insensitive or warm-sensitive neurons were found in higher 
proportions, though warm-sensitive neurons were located in relative proximity to the 
fornix.   
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Figure 15.  Electrode locations for recordings of single neuron activity in response to temperature 
and Cirazoline with COX-2 inhibition. Section diagrams are shown in the coronal plane and 
ordered from rostral to caudal, beginning with the upper left section and moving across each row. 
Distance from bregma: A = − 0.5 mm; B = − 0.7 mm; C = − 1.0 mm; D = − 1.3 mm.  Sections 
were adapted from an atlas of the rat brain (Paxinos and Watson, 1998). Circles ● = insensitive 
neurons, Squares ■ = warm-sensitive neurons.  Key abbreviations same as in Figure 11.   
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Discussion 
 
 The fever response is an important mechanism in the body’s line of defense 
against immune system challenges.  Traditionally, it was believed that PGE2 was the 
critical fever signal, produced either via circulating or fixed mononuclear phagocytes in 
the periphery.  Once transported in the bloodstream, PGE2 would enter the AH by means 
of transport through permeable areas of the blood brain barrier (Blatteis, 1997).  
However, this mechanism is rather slow, and it could not account for the fact that COX-2 
expression actually appeared much later than the actual onset of fever. This suggests that 
a mechanism independent of PGE2 production was driving the initial fever response. 
 Recent in vivo research instead demonstrates that it is hepatic vagal afferents 
which promptly convey information from the immune system to the hypothalamus to 
initiate a fever in response to a peripheral LPS challenge.  Via this neural route, it is the 
subsequent release of NE within the AH which is a critical fever mediator through its 
action at α1 and α2 ARs of thermoregulatory neurons (Feleder et al., 2007).  Stimulation 
of α1 ARs gives rise to a prompt temperature rise independent of PGE2, whereas 
activation of α2 ARs yields a biphasic response, producing an initial hypothermia and 
later generating a temperature rise that is dependent on COX-2 derived PGE2 synthesis 
(Feleder et al., 2004).  This twofold mechanism can better account for the prompt, initial 
temperature rise and the slower elevation of PGE2 levels.  Therefore, NE acting at α1 
ARs must directly augment the firing rates of thermoregulatory neurons to quickly 
generate heat production, while the simultaneous activation of α2 ARs would initiate 
second messenger pathways responsible for downstream PGE2 synthesis.  In this sense, 
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NE is more a fever initiator, whereas PGE2 acts later through EP receptors and is 
responsible for sustaining this hyperthermia.   
 This study analyzed the responses of thermoregulatory neurons within an AH 
tissue slice preparation in the presence of selective α1 and α2 AR agonists while 
production of COX-2 derived PGE2 was inhibited.  It is important to complement in vivo 
research with in vitro methodology to better understand the properties of 
thermoregulatory neurons driving these NE-mediated thermal responses.  Confirmation 
of the PGE2-independence and PGE2-dependence of these two respective pathways can 
provide more support for the neural mechanism of fever induction and a better 
understanding of thermoregulatory synaptic networks in the AH. 
 Hammel’s (1965) model outlines an elegant six neuron synaptic network in the 
AH to account for changes of a thermoregulatory set-point.  It is centered on mutually 
antagonistic synapses of warm-sensitive and temperature insensitive neurons with 
effector neurons that control thermoregulatory responses.  Warm-sensitive neurons 
synaptically excite heat-loss effector neurons and inhibit heat-production effector neurons 
whereas the temperature insensitive neurons inhibit heat-loss effector neurons and excite 
heat-production effector neurons.  Thus, the inhibition of warm-sensitive neurons and 
excitation of temperature insensitive neurons would produce a hyperthermic shift of set-
point temperature.  In contrast, excitation of warm-sensitive neurons and inhibition of 
temperature insensitive neurons would drive the set-point into a hypothermic range.   
 In this study, perfusion of the α1 AR agonist with COX-2 inhibition resulted in 
firing rate changes in agreement with Hammel’s model.  The majority of temperature 
insensitive neurons showed a rapid increase in firing rate when exposed to Cirazoline, 
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whereas both warm-sensitive neurons exhibited a long term shutdown.  For comparison, 
the data from a previous study analyzing Cirazoline’s effects without COX-2 inhibition 
(Imbery et al., 2008) is included.  Although the sample size for this study is noticeably 
smaller and lacking in warm-sensitive cells, the results are very similar.  Between both 
groups, the most striking similarity is the response of the temperature insensitive neurons, 
each reaching average treatment firing rates near 10 impulses·s− 1, the slight difference 
not being significant.   Though there is a significant difference between the degree of 
inhibition for warm-sensitive neurons from these two studies, it is likely due to the low 
sample size in the present study.  The lack of warm-sensitive cells in this study may be a 
result of more recordings being made near the third ventricle (midline) as opposed to 
more lateral areas near the fornix, where there are greater proportions of warm-sensitive 
neurons (Griffin et al., 2001).   
 Together, these findings suggest that the effect of NE at the α1 AR is responsible 
for directly modifying the firing rate of temperature sensitive and warm-sensitive neurons 
to drive set-point into a hyperthermic range.  It also supports evidence that the α1 AR is 
widely localized on neurons within the AH, but the specific subtype remains to be 
identified.  Since it is a rapid response, it presumably involves modification of ion 
channel conductances, via a mechanism related to the α1 AR stimulation of PLC 
production, perhaps involving calcium.  Further intracellular analysis will be needed to 
discern the specific conductances involved.  Generally in the brain, α1 activation is 
excitatory and results in slow depolarization linked to the inhibition of potassium 
channels (Purves et al., 2004).  As well, molecular evidence suggests that the α1 mediates 
an increase in sodium pump activity (Mallick et al., 2000).  Given that the α1 AR is 
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responsible for the initial temperature rise and not maintaining later phases, the 
hyperthermic affect of Cirazoline likely attenuates due to receptor desensitization after 
continuous stimulation.  But by the time the α1 AR response attenuates, the levels of 
PGE2 will have risen due to α2 AR activation, thus bringing about the second phase of 
fever maintenance. 
 Perfusion of the α2 AR agonist Clonidine produces a biphasic response, a 
hypothermia followed by late phase hyperthermia.  Hammel’s model predicts that this 
initial hypothermia would be driven by an increase in firing rate of warm-sensitive 
neurons and a decrease in firing rate of temperature insensitive neurons, just the opposite 
of what was observed with Cirazoline α1 AR stimulation.  The findings from this study 
support Clondine’s direct hypothermic effects.  Despite COX-2 inhibition, twenty-four 
out of twenty-seven insensitive neurons decreased their firing rate in response to 
Clonidine.  Two warm-sensitive neurons significantly increased their firing rate in 
response to Clondine, but there was one warm-sensitive neuron which did show a drastic 
decrease in firing rate.  It is difficult to reach an accurate conclusion of Clonidine’s affect 
on warm-sensitive neurons with a small sample size of three.  As the case with the 
Cirazoline COX-2 inhibition data, the lack of warm-sensitive cells recorded in this study 
may be attributed to recordings being made closer to the third ventricle.  It does not 
appear that the COX-2 inhibitor Meloxicam was decreasing the probability of recording 
from warm-sensitive neurons or that it reduced the inherent thermosensitivities of these 
neurons, though more controls in this regard could be performed for confirmation.   
 This data suggests that Clonidine’s action at the α2 AR results in direct 
modification of ion conductances in thermoregulatory neurons to establish a hypothermic 
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set-point.  How this occurs remains to be elucidated, but intracellular recordings could 
provide answers in this regard.  In contrast to the α1 AR, α2 stimulation usually results in 
a slow hyperpolarization due to activation of potassium channels (Purves et al., 2004), 
and these antagonistic affects may account for the different thermal responses they 
mediate.   But the question remains about these two opposite thermal responses which 
would initially be competing when NE is released in the AH.  Presumably, the 
hypothermic α2 affect is masked by simultaneous, more profound α1 stimulation, 
producing a net hyperthermia.  This could be tested by administration of Clonidine and 
Cirazoline together or either NE directly.  The NE hyperthermic effects should manifest 
and occur in succession; the first (Cirazoline) rapid in onset, α1 AR mediated and the 
second (Clonidine) delayed, α2 AR mediated and PGE2-dependent.  
 In this study, nine temperature insensitive neurons were recorded for a period of 
at least thirty minutes after Clonidine administration to examine late phase response.  If 
PGE2 is responsible for driving a late phase hyperthermia, Hammel’s model predicts an 
increase and decrease in firing rate of temperature insensitive and warm-sensitive 
neurons, respectively, to shift set-point, similar to what is observed for Cirazoline.  In all 
of these neurons, none showed a significant, prolonged rise in firing rate that is typical of 
a PGE2 response (Ranels and Griffin, 2003).  Although this study is limited since PGE2 
levels were not actually measured, these findings provide more evidence that a COX-2 
dependent PGE2 pathway is indeed responsible for producing the late phase α2 response.  
The interaction between NE and PGE2 during fever is well documented (Sehic et al., 
1996), and the likely intermediary is cAMP.  Activation of the α2 AR is often coupled 
with inhibition of adenylate cyclase, thus decreased cAMP production may be leading to 
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increased PGE2 synthesis and release, though an exact mechanism is unknown.  PGE2 
would then exert direct effects on thermoregulatory neurons via an EP3 or EP4 mediated 
pathway to raise the set-point.   
 Together, this study has contributed more support for a biphasic fever mechanism 
mediated by NE within the AH thermoregulatory network described by Hammel (1965).  
The first phase is mediated rapidly by the α1 AR, directly augmenting the firing rate of 
thermoregulatory neurons in accordance with Hammel’s model in a PGE2-independent 
pathway.  As well, the initial α2 AR stimulation produces a PGE2 -independent 
hypothermia via contrasting responses of these thermoregulatory neurons, but this is 
likely masked by the simultaneous α1 AR pathway.  The late phase is dependent on α2 
AR activation of downstream COX-2 derived PGE2 production, which then acts to 
maintain the set-point temperature within a hyperthermic range.   
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